<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>全球视野下的中国创新药产业：十年回顾与展望</title>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <link href="https://unpkg.com/aos@2.3.1/dist/aos.css" rel="stylesheet">
    <style>
        @import url('https://fonts.googleapis.com/css2?family=Noto+Sans+SC:wght@400;700&family=Roboto:wght@300;400&display=swap');

        :root {
            --primary-color: #0071e3; /* Apple blue inspired */
            --highlight-color-1: rgba(0, 113, 227, 0.8); /* Primary highlight */
            --highlight-color-2: rgba(50, 170, 255, 0.7); /* Secondary highlight */
            --text-color: #1d1d1f;
            --secondary-text-color: #515154;
            --background-color: #f5f5f7;
            --white-color: #ffffff;
            --border-color: rgba(0, 0, 0, 0.1);
            --scroll-behavior: smooth; /* Use smooth scrolling */
        }

        /* Apply smooth scroll behavior globally */
        html {
           scroll-behavior: var(--scroll-behavior);
        }


        body {
            font-family: 'Noto Sans SC', 'Roboto', sans-serif;
            margin: 0;
            padding: 0;
            background-color: var(--background-color);
            color: var(--text-color);
            overflow-x: hidden; /* Prevent horizontal scroll */
        }

        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 20px;
            box-sizing: border-box;
        }

        /* --- Header & Title --- */
        header {
            min-height: 90vh;
            display: flex;
            align-items: center;
            justify-content: center;
            text-align: center;
            position: relative;
            overflow: hidden;
            background: linear-gradient(135deg, var(--background-color) 50%, var(--white-color) 100%);
            padding: 40px 20px;
        }

        .header-content {
            z-index: 1;
            max-width: 90%; /* Ensure content doesn't touch edges */
        }

        .main-title {
            font-size: clamp(3rem, 8vw, 6rem);
            font-weight: 700;
            color: var(--text-color);
            margin-bottom: 10px;
            line-height: 1.1;
            display: inline-block; /* Needed for typewriter width */
        }

        .main-title .typewriter {
            border-right: .10em solid var(--primary-color);
            white-space: nowrap;
            overflow: hidden;
            display: block; /* Make it block inside title */
            animation: typing-main 3.5s steps(30, end) forwards, /* Use 'forwards' to keep final state */
                       blink-caret .75s step-end 5; /* Blink only during typing */
            width: 0; /* Start with 0 width */
        }

        .subtitle {
            font-size: clamp(1.2rem, 3vw, 1.8rem);
            color: var(--secondary-text-color);
            font-weight: 300;
            max-width: 700px;
            margin: 10px auto 0 auto; /* Adjust margin */
            white-space: nowrap; /* Keep subtitle on one line for effect */
            overflow: hidden;
            width: 0; /* Start hidden */
            opacity: 0; /* Start invisible */
            animation: typing-sub 3s steps(40, end) 3.6s forwards, /* Delay start after main title */
                       blink-caret-sub .75s step-end 3.6s 4; /* Blink during typing, delayed */
        }

        /* Typing Animations */
        @keyframes typing-main {
            from { width: 0 }
            to { width: 100% }
        }
        @keyframes typing-sub {
             0% { width: 0; opacity: 1;} /* Become visible when starting */
            100% { width: 100%; opacity: 1;}
        }

        /* Separate blink animations */
        @keyframes blink-caret {
            from, to { border-color: transparent }
            50% { border-color: var(--primary-color); }
        }
         @keyframes blink-caret-sub {
             from, to { border-right-color: transparent } /* Add cursor to subtitle */
             50% { border-right-color: var(--primary-color); }
         }
        /* Apply subtitle cursor via pseudo-element if direct animation is tricky */
        .subtitle {
             border-right: .10em solid transparent; /* Add space for potential cursor */
        }


        .header-visual {
            position: absolute;
            bottom: -15%;
            left: 50%;
            transform: translateX(-50%) scale(1.5);
            font-size: clamp(15rem, 40vw, 30rem);
            color: rgba(0, 113, 227, 0.05);
            font-weight: 700;
            z-index: 0;
            line-height: 1;
            user-select: none;
        }
        /* --- End Header Section --- */

        /* --- Main Content Styling --- */
        main {
            display: block;
        }

        section {
            padding: 60px 0;
            border-bottom: 1px solid var(--border-color);
            background-color: var(--white-color);
        }
        section:nth-child(odd) {
             background-color: var(--background-color);
        }
        section:last-of-type {
            border-bottom: none;
        }

        .section-title-cn {
            font-size: clamp(2rem, 4.5vw, 3rem);
            font-weight: 700;
            margin-bottom: 5px;
            color: var(--text-color);
        }

        .section-title-en {
            font-size: clamp(0.8rem, 1.8vw, 1.1rem);
            font-weight: 400;
            color: var(--secondary-text-color);
            text-transform: uppercase;
            letter-spacing: 1px;
            margin-bottom: 30px;
        }

        h2 { /* Section Title Container */
            text-align: center;
            margin-bottom: 40px;
        }

        h3 { /* Subsection Titles */
             font-size: 1.5rem;
             font-weight: 700;
             color: var(--primary-color);
             margin-top: 30px;
             margin-bottom: 15px;
             border-left: 4px solid var(--primary-color);
             padding-left: 10px;
        }

        p, ul {
            font-size: 1.05rem;
            line-height: 1.8;
            color: var(--secondary-text-color);
            max-width: 850px;
            margin: 15px auto;
        }
        ul {
            list-style: none;
            padding-left: 0; /* Remove default padding */
            margin-left: 10px; /* Add margin to UL container */
        }
        ul li {
            padding-left: 2em; /* Increased padding for list item text */
            position: relative;
            margin-bottom: 12px; /* Slightly more space */
        }
         /* Custom bullet - adjusted position */
        ul li::before {
            content: '';
            position: absolute;
            left: 0.5em; /* Position bullet within the increased padding */
            top: 0.5em;
            width: 8px;
            height: 8px;
            background-color: var(--primary-color);
            border-radius: 50%;
        }

        /* Highlight & Tech Feel */
        .highlight-1, .highlight-2 {
            font-weight: bold;
        }
        .highlight-1 {
            background: linear-gradient(to bottom, var(--highlight-color-1), rgba(0, 113, 227, 0));
            -webkit-background-clip: text;
            color: transparent;
            display: inline;
        }
        .highlight-2 {
             background: linear-gradient(to bottom, var(--highlight-color-2), rgba(50, 170, 255, 0));
            -webkit-background-clip: text;
            color: transparent;
            display: inline;
        }

        /* Data Point Styling */
        .data-point {
            border: 2px solid var(--primary-color);
            border-radius: 8px;
            padding: 20px;
            margin: 20px 0;
            text-align: center;
            background-color: rgba(255, 255, 255, 0.6);
            backdrop-filter: blur(5px);
            transition: transform 0.3s ease, box-shadow 0.3s ease;
        }
        .data-point:hover {
             transform: translateY(-5px);
             box-shadow: 0 10px 20px rgba(0,0,0,0.05);
         }
        .data-point .value {
            font-size: clamp(1.8rem, 4vw, 2.5rem);
            font-weight: 700;
            color: var(--primary-color);
            display: block;
            margin-bottom: 5px;
        }
        .data-point .label {
            font-size: 0.9rem;
            color: var(--secondary-text-color);
        }

        /* Chart Container Styling */
        .chart-container {
            position: relative;
            margin: 40px auto;
            padding: 20px;
            max-width: 900px; /* Limit width */
            width: 100%; /* Take available width */
            height: 400px; /* Fixed height */
            background-color: var(--white-color);
            border-radius: 10px;
            box-shadow: 0 5px 15px rgba(0,0,0,0.05);
        }
         .chart-container canvas {
             max-width: 100%;
             height: auto;
         }


        /* Flexbox Layout */
        .flex-container {
            display: flex;
            flex-wrap: wrap;
            gap: 40px; /* Increased gap for more space */
            align-items: flex-start;
        }
        .flex-item {
            flex: 1;
            min-width: 320px;
            /* Add margin for explicit spacing, especially on wrap */
            margin-bottom: 20px;
        }

        .flex-item.text-content {
            text-align: left;
        }
         .flex-item.text-content p,
         .flex-item.text-content ul {
             margin-left: 0;
             margin-right: 0;
             max-width: 100%;
         }
         .flex-item.text-content h3 {
             margin-top: 0;
         }

        /* Scroll Effects (AOS) */
        [data-aos] {
            opacity: 0;
            transition-property: transform, opacity;
        }

        /* Footer */
        footer {
            text-align: center;
            padding: 30px 20px;
            background-color: #e9e9eb;
            color: var(--secondary-text-color);
            font-size: 0.9rem;
            margin-top: 50px;
        }

        /* Back to Top Button Styling */
        #backToTopBtn {
            display: none; /* Hidden by default */
            position: fixed; /* Fixed position */
            bottom: 30px; /* Distance from bottom */
            right: 30px; /* Distance from right */
            z-index: 99; /* Stay on top */
            border: none; /* Remove border */
            outline: none; /* Remove outline */
            background-color: var(--primary-color); /* Button color */
            color: white; /* Text color */
            cursor: pointer; /* Add cursor */
            padding: 12px 15px; /* Padding */
            border-radius: 50%; /* Make it round */
            font-size: 16px; /* Increase font size */
            line-height: 1;
            box-shadow: 0 4px 8px rgba(0,0,0,0.2);
            transition: background-color 0.3s, opacity 0.3s, visibility 0.3s;
        }

        #backToTopBtn:hover {
            background-color: #0056b3; /* Darker blue on hover */
        }


        /* Responsive Adjustments */
        @media (max-width: 768px) {
             .flex-item { min-width: 100%; margin-bottom: 10px;}
             .flex-container { gap: 20px; } /* Reduce gap on mobile */
             .flex-item.text-content { text-align: left; }
             .flex-item.text-content p,
             .flex-item.text-content ul { margin: 15px auto; max-width: 95%; }
             .main-title { font-size: 2.5rem; }
            /* Subtitle animation might look odd on mobile, could hide it */
             .subtitle { font-size: 1.1rem; white-space: normal; width: auto; animation: none; opacity: 1; border-right: none;}
             .section-title-cn { font-size: 1.8rem; }
             .section-title-en { font-size: 0.8rem; }
            .chart-container { height: 300px; } /* Smaller charts */
            .data-point .value { font-size: 1.8rem; }
             h3 { font-size: 1.3rem; }
             p, ul { font-size: 1rem; }
             ul li { padding-left: 1.8em; } /* Adjust padding */
             ul li::before { left: 0.4em; } /* Adjust bullet position */
             #backToTopBtn { bottom: 20px; right: 20px; padding: 10px 12px; font-size: 14px; }
        }

    </style>
</head>
<body>

    <header>
        <div class="header-content">
            <h1 class="main-title"><span class="typewriter">中国创新药产业</span></h1>
            <p class="subtitle">全球视野下的十年回顾与展望 (2015-2024)</p>
        </div>
        <div class="header-visual">10</div>
    </header>

    <main>
        <section id="overview">
            <div class="container">
                <h2 data-aos="fade-up">
                    <span class="section-title-cn">产业全景</span><br>
                    <span class="section-title-en">INDUSTRY OVERVIEW (2015-2024)</span>
                </h2>
                <p data-aos="fade-up" data-aos-delay="100">
                    2015年以来，中国创新药产业迎来历史性转折。面对审评积压、低水平仿制等困境，国家启动了深刻的“医药供给侧改革”。通过改革审评审批制度、优化医保准入、打通资本市场渠道等一系列政策组合拳（“三医联动”），为产业注入强大动力，推动中国从创新追随者向全球竞争重要力量转变。
                </p>
                <div class="flex-container">
                    <div class="flex-item text-content" data-aos="fade-right" data-aos-delay="200">
                         <h3><span class="highlight-1">十年成就</span> Decade Achievements</h3>
                         <ul>
                              <li><span class="highlight-2">研发领跑：</span>截至2024年，中国企业自主研发的活跃创新药数量达 <span class="highlight-1">3,575个</span>，超越美国位居全球首位，细胞疗法和小分子药最多。</li>
                              <li><span class="highlight-2">本土崛起：</span>国产创新药在中国获批上市的比例从2015年的不足10%增至2024年的 <span class="highlight-1">42%</span>，共获批39个。</li>
                              <li><span class="highlight-2">转化加速：</span>中国成为全球创新药首发上市的“第一梯队”，2024年首发上市药物占全球近 <span class="highlight-1">38%</span>。</li>
                              <li><span class="highlight-2">用药可及：</span>中美新药上市时间差从改革前的约8年显著缩短至 <span class="highlight-1">2年</span> 以内，部分新药甚至在中国率先获批。</li>
                              <li><span class="highlight-2">市场增长：</span>核心医院市场规模达 <span class="highlight-1">8,822亿元</span> (2024E)，创新药占比从21%增至 <span class="highlight-1">29%</span>。</li>
                              <li><span class="highlight-2">资本助力：</span>一二级市场累计融资超 <span class="highlight-1">1.23万亿元</span>，港交所18A、科创板等拓宽融资渠道，产业集群效应显著。</li>
                              <li><span class="highlight-2">全球布局：</span>对外授权 (License-out) 交易总额超 <span class="highlight-1">1500亿</span> 美元，2024年单年达519亿美元；已有 <span class="highlight-1">18款</span> 中国原研新药在海外获批上市。</li>
                         </ul>
                    </div>
                    <div class="flex-item" data-aos="fade-left" data-aos-delay="300">
                        <div class="data-point">
                            <span class="value">30%+</span>
                            <span class="label">2024年中国FIC创新药占新增研发比例</span>
                        </div>
                         <div class="data-point">
                            <span class="value">>50%</span>
                            <span class="label">2024年美国IND申请中来自中国的分子比例 (by Scott Gottlieb)</span>
                        </div>
                         <div class="data-point">
                            <span class="value">10%</span>
                            <span class="label">2015年后上市创新药占2024年核心医院市场份额</span>
                        </div>
                    </div>
                </div>
            </div>
        </section>

        <section id="rd-trends">
            <div class="container">
                 <h2 data-aos="fade-up">
                    <span class="section-title-cn">研发趋势</span><br>
                    <span class="section-title-en">R&D TRENDS</span>
                </h2>
                 <p data-aos="fade-up" data-aos-delay="100">
                    全球创新药研发数量持续攀升，中国成为最主要的增长引擎。研发管线呈现多元化，细胞疗法、小分子药物是主力，ADC、双抗/多抗、放射性药物等新技术崭露头角。中国正努力从“快速跟随”向“源头创新”转变，FIC药物研发潜力不断释放。
                 </p>
                 <div class="flex-container">
                     <div class="flex-item" data-aos="zoom-in" data-aos-delay="200">
                         <div class="chart-container">
                             <canvas id="rdCountChart"></canvas> </div>
                         <p style="text-align:center; font-size: 0.9rem; color: var(--secondary-text-color);">图：全球主要国家/地区创新药年研发数量 (款)</p>
                    </div>
                     <div class="flex-item text-content" data-aos="fade-left" data-aos-delay="300">
                         <h3><span class="highlight-1">研发格局</span> R&D Landscape</h3>
                          <ul>
                              <li><span class="highlight-2">全球增长：</span>2015-2024年全球累计研发 <span class="highlight-1">12,263款</span> 创新药，年均超1300款进入临床 (近五年)。</li>
                              <li><span class="highlight-2">中国引领：</span>中国企业年研发数量从100款增至 <span class="highlight-1">704款</span> (2024)，超越美国。</li>
                              <li><span class="highlight-2">药物类型：</span>细胞疗法 (<span class="highlight-1">21%</span>) 和小分子 (<span class="highlight-1">20%</span>) 占比最高，其次是单抗 (8%)，新兴技术如放射性药物 (5%)、双/多抗 (4%) 增多。</li>
                              <li><span class="highlight-2">靶点热度：</span>全球热门靶点Top20中国重合度 <span class="highlight-1">80%</span>，并在CD19、BCMA、CLDN18.2等靶点贡献超 <span class="highlight-1">50%</span> 甚至 <span class="highlight-1">80%</span> 的药品数量。</li>
                              <li><span class="highlight-2">FIC突破：</span>中国FIC创新药研发数量全球第二，2024年达 <span class="highlight-1">120个</span>，占当年新增研发超30%。</li>
                              <li><span class="highlight-2">临床试验：</span>中国企业临床试验数年复合增长 <span class="highlight-1">18.8%</span>，2024年超1900项，但国际多中心试验占比较低 (约10%)。</li>
                          </ul>
                     </div>
                </div>
            </div>
        </section>

        <section id="commercialization">
            <div class="container">
                 <h2 data-aos="fade-up">
                    <span class="section-title-cn">商业化趋势</span><br>
                    <span class="section-title-en">COMMERCIALIZATION TRENDS</span>
                </h2>
                 <p data-aos="fade-up" data-aos-delay="100">
                     创新药的最终目的是惠及患者。中国通过常态化医保谈判机制，极大缩短了新药从获批到纳入医保的时间，加速市场准入。核心医院市场稳步增长，国产创新药份额提升，但“进院难”成为新的瓶颈，“腾笼换鸟”在不同治疗领域速度不一。
                 </p>
                <div class="flex-container">
                     <div class="flex-item text-content" data-aos="fade-right" data-aos-delay="200">
                        <h3><span class="highlight-1">市场准入与表现</span> Market Access & Performance</h3>
                        <ul>
                            <li><span class="highlight-2">医保加速：</span>近四年谈判成功的新药 <span class="highlight-1">~90%</span> 在获批2年内进入医保目录，实现“以时间换空间”。</li>
                            <li><span class="highlight-2">市场扩容：</span>核心医院（占全国~50%份额）药品市场规模达 <span class="highlight-1">8822亿</span> (2024E)，创新药占比增至 <span class="highlight-1">29%</span>。</li>
                            <li><span class="highlight-2">国产替代：</span>中国企业研发的创新药市场份额从18.7%升至 <span class="highlight-1">27.8%</span> (2015-2024)，2015年后上市的国产新药贡献显著 (达11.3%)。</li>
                            <li><span class="highlight-2">领域分化：</span>抗肿瘤和免疫调节剂是创新药主战场，市场份额增长最快；而呼吸、激素等领域仿制药仍占主导。</li>
                            <li><span class="highlight-2">院外市场：</span>DTP药房等院外渠道重要性凸显，承接大量处方，PD-1、EGFR、VEGFR等靶点药物院外销售占比高 (达30-44%)。</li>
                            <li><span class="highlight-2">进院困境：</span>新药上市后进入医院目录比例低（京粤约 <span class="highlight-1">50%</span>），且进入后覆盖医院范围窄（平均 <span class="highlight-1">10-12%</span>），影响患者可及性。</li>
                        </ul>
                    </div>
                     <div class="flex-item" data-aos="zoom-in" data-aos-delay="300">
                         <div class="chart-container">
                              <canvas id="marketShareChart"></canvas> </div>
                         <p style="text-align:center; font-size: 0.9rem; color: var(--secondary-text-color);">图：中外企业创新药市场规模 (亿人民币)</p>
                    </div>
                </div>
            </div>
        </section>

        <section id="investment">
            <div class="container">
                 <h2 data-aos="fade-up">
                    <span class="section-title-cn">投融资趋势</span><br>
                    <span class="section-title-en">INVESTMENT & FINANCING TRENDS</span>
                </h2>
                 <p data-aos="fade-up" data-aos-delay="100">
                     资本是创新药研发的“燃料”。过去十年，政策红利和资本市场开放（港交所18A、科创板）点燃了投融资热潮，累计融资超 <span class="highlight-1">1.23万亿</span>。然而，自2021年全球生物科技进入调整期，中国也经历“资本寒冬”，融资额连续下滑，IPO遇冷，退出渠道受阻。
                 </p>
                <div class="flex-container">
                    <div class="flex-item" data-aos="zoom-in" data-aos-delay="200">
                        <div class="chart-container">
                            <canvas id="investmentChart"></canvas> </div>
                         <p style="text-align:center; font-size: 0.9rem; color: var(--secondary-text-color);">图：中国创新药领域一、二级市场融资额 (亿人民币)</p>
                    </div>
                     <div class="flex-item text-content" data-aos="fade-left" data-aos-delay="300">
                        <h3><span class="highlight-1">资本脉动</span> Capital Pulse</h3>
                        <ul>
                            <li><span class="highlight-2">全球周期：</span>全球一级市场创新药融资在2021年达 <span class="highlight-1">551亿</span> 美元高峰后回落，但ADC、小核酸、放射性药物等领域仍有亮点。</li>
                            <li><span class="highlight-2">中国寒冬：</span>中国医药领域融资额连续4年下滑，2024年较2020高点缩水 <span class="highlight-1">76%</span>。IPO数量锐减，2024年仅 <span class="highlight-1">7家</span> 创新药企上市。</li>
                            <li><span class="highlight-2">融资渠道：</span>港交所18A累计融资超 <span class="highlight-1">1100亿</span> 港币 (56家)，科创板第五套标准为未盈利企业打开A股大门。</li>
                            <li><span class="highlight-2">集群效应：</span>超 <span class="highlight-1">50%</span> 资本涌入上海张江、北京中关村、苏州BioBay等生物医药基地。</li>
                            <li><span class="highlight-2">退出多元化：</span>IPO受阻下，并购 (M&A) 成为重要退出方式，国内并购活动在2024年显著增加 (达<span class="highlight-1">22起</span>)。NewCo模式（剥离管线成立海外新公司）也成为探索方向。</li>
                        </ul>
                    </div>
                </div>
            </div>
        </section>

        <section id="globalization">
            <div class="container">
                <h2 data-aos="fade-up">
                    <span class="section-title-cn">出海趋势</span><br>
                    <span class="section-title-en">GLOBALIZATION TRENDS</span>
                </h2>
                <p data-aos="fade-up" data-aos-delay="100">
                    面对国内竞争加剧和资本压力，走向全球市场成为中国创新药企的必然选择。通过自主研发国际化或对外授权 (License-out) 合作，中国药企正加速融入全球产业链，提升品牌价值和获取回报。
                </p>
                 <div class="flex-container">
                      <div class="flex-item text-content" data-aos="fade-right" data-aos-delay="200">
                        <h3><span class="highlight-1">扬帆远航</span> Sailing Globally</h3>
                        <ul>
                            <li><span class="highlight-2">出海里程碑：</span>自2019年泽布替尼在美国获批以来，已有 <span class="highlight-1">18款</span> 中国原研创新药在海外上市，2024年新增6款。</li>
                            <li><span class="highlight-2">授权交易火爆：</span>2024年License-out交易达 <span class="highlight-1">94笔</span>，总金额 <span class="highlight-1">519亿</span> 美元，首付款 <span class="highlight-1">41亿</span> 美元，均创新高。</li>
                            <li><span class="highlight-2">主要伙伴：</span>美国企业是主要受让方 (占<span class="highlight-1">49%</span>交易量，<span class="highlight-1">55%</span>总金额)。Biotech是主要转让方，但跨国巨头 (TOP MNC) 兴趣浓厚，2024年达成 <span class="highlight-1">29笔</span> 交易。</li>
                            <li><span class="highlight-2">权益分配：</span>多以全球权益 (35%) 或美欧日主流地区权益 (42%) 转让为主。</li>
                            <li><span class="highlight-2">技术前沿：</span>交易项目类型多样化，抗体药 (尤其ADC)、细胞基因疗法、小核酸受青睐。临床前项目交易占比超 <span class="highlight-1">60%</span> (2024)，显示MNC向早期布局。</li>
                            <li><span class="highlight-2">风险显现：</span>出海并非一帆风顺，已有自主项目失败，<span class="highlight-1">36个</span> 交易项目因疗效、审批、商业策略等原因终止或暂停。</li>
                        </ul>
                     </div>
                      <div class="flex-item" data-aos="zoom-in" data-aos-delay="300">
                         <div class="chart-container">
                            <canvas id="licenseOutChart"></canvas> </div>
                        <p style="text-align:center; font-size: 0.9rem; color: var(--secondary-text-color);">图：中国药企 License-out 交易金额 (亿美元) 与数量 (件)</p>
                    </div>
                </div>
            </div>
        </section>

        <section id="challenges-outlook">
            <div class="container">
                 <h2 data-aos="fade-up">
                    <span class="section-title-cn">挑战与展望</span><br>
                    <span class="section-title-en">CHALLENGES & OUTLOOK</span>
                </h2>
                 <p data-aos="fade-up" data-aos-delay="100">
                     尽管成就显著，但中国创新药产业仍面临严峻挑战：研发同质化内卷严重、医保支付体系单一且降价压力大、医院准入梗阻（“最后一公里”）、资本寒冬持续、源头创新能力不足等。要实现从“跟随”到“引领”，从“规模”到“价值”的跨越，需要系统性解决这些序贯性瓶颈。
                 </p>
                 <h3 data-aos="fade-up" data-aos-delay="150"><span class="highlight-1">破局之路</span> Path Forward</h3>
                 <ul>
                     <li data-aos="fade-up" data-aos-delay="200"><span class="highlight-2">优化竞争生态：</span>遏制无序内卷，对FIC/BIC等高价值创新给予优先准入、价格保护、专利补偿、数据保护等激励，避免“后来者掀桌子”。</li>
                     <li data-aos="fade-up" data-aos-delay="250"><span class="highlight-2">构建多元支付：</span>平衡患者负担与企业回报。除医保外，大力发展商业健康险，探索创新支付模式，给予高价值创新药合理定价空间和时间窗，医保价格需保密以支持国际化。</li>
                     <li data-aos="fade-up" data-aos-delay="300"><span class="highlight-2">深化三医联动：</span>打通新药进院“最后一公里”，改革医院考评机制，解决医院引进创新药动力不足问题，确保创新成果能快速惠及患者，保护创新者领先优势。</li>
                     <li data-aos="fade-up" data-aos-delay="350"><span class="highlight-2">完善资本生态：</span>打通融资、上市、退出的良性循环。设立政府引导基金支持早期创新，稳定市场预期，缓解企业融资困境和“卖青苗”现象。</li>
                     <li data-aos="fade-up" data-aos-delay="400"><span class="highlight-2">接轨国际标准：</span>深入理解国际规则，提升临床设计、注册申报能力。推动审评审批标准互认，支持企业拓展“一带一路”等新兴市场。</li>
                     <li data-aos="fade-up" data-aos-delay="450"><span class="highlight-2">强化源头创新：</span>加大基础研究投入，聚焦重大疾病机制和新靶点发现。完善成果转化机制，允许科研人员参与利益分配，构建从基础到产业的创新闭环。</li>
                 </ul>
                 <p data-aos="fade-up" data-aos-delay="500">
                    展望未来十年，通过政策精准发力与市场高效协同，中国创新药产业有望实现从规模驱动到价值创造的质变，在全球健康事业中扮演更重要的角色。
                 </p>

            </div>
        </section>
    </main>

    <footer>
        <p>友情提示：本页内容仅作参考</p>
    </footer>

    <button id="backToTopBtn" title="返回顶部">↑</button>

    <script src="https://unpkg.com/aos@2.3.1/dist/aos.js"></script>
    <script>
        // Initialize AOS (Animate on Scroll)
        AOS.init({
            duration: 800,
            once: true,
            offset: 100,
            disable: 'mobile'
        });

        // Chart.js & Back to Top Button Logic
        document.addEventListener('DOMContentLoaded', () => {

            // --- Back to Top Button Logic ---
            const backToTopButton = document.getElementById("backToTopBtn");

            window.onscroll = function() { scrollFunction(); };

            function scrollFunction() {
                if (backToTopButton) {
                     if (document.body.scrollTop > 300 || document.documentElement.scrollTop > 300) {
                        backToTopButton.style.display = "block";
                     } else {
                        backToTopButton.style.display = "none";
                     }
                }
            }

            if (backToTopButton) {
                backToTopButton.addEventListener('click', () => {
                     window.scrollTo({ top: 0 }); // Use smooth scroll from CSS
                 });
            }

            // --- Chart.js Implementations ---

            // Helper function to safely get context and create chart
             function safeCreateChart(canvasId, config) {
                const canvas = document.getElementById(canvasId);
                 // Delay chart creation slightly to ensure layout is stable after potential AOS shifts
                setTimeout(() => {
                    if (!canvas) {
                        console.warn(`Canvas element with ID '${canvasId}' not found.`);
                        return;
                    }
                     const ctx = canvas.getContext('2d');
                     if (!ctx) {
                         console.error(`Failed to get 2D context for canvas ID: ${canvasId}`);
                         return;
                     }
                     try {
                        new Chart(ctx, config);
                        console.log(`Chart created successfully for canvas ID: ${canvasId}`);
                     } catch (e) {
                        console.error(`Error creating chart for canvas ID: ${canvasId}`, e);
                     }
                }, 100); // Small delay
             }


            // --- R&D Count Chart ---
            const rdConfig = {
                type: 'line',
                data: { /* Data as before */
                    labels: ['2015', '2016', '2017', '2018', '2019', '2020', '2021', '2022', '2023', '2024'],
                    datasets: [
                        { label: '中国 China', data: [100, 163, 190, 238, 265, 360, 409, 411, 541, 704], borderColor: 'rgba(0, 113, 227, 1)', backgroundColor: 'rgba(0, 113, 227, 0.1)', borderWidth: 2, tension: 0.3, pointRadius: 4, pointBackgroundColor: 'rgba(0, 113, 227, 1)', fill: true },
                        { label: '美国 USA', data: [283, 300, 267, 302, 342, 440, 451, 440, 420, 440], borderColor: 'rgba(255, 159, 10, 1)', backgroundColor: 'rgba(255, 159, 10, 0.1)', borderWidth: 2, tension: 0.3, pointRadius: 4, pointBackgroundColor: 'rgba(255, 159, 10, 1)', fill: true },
                        { label: '欧洲 Europe', data: [180, 197, 207, 188, 209, 221, 229, 206, 212, 167], borderColor: 'rgba(48, 209, 88, 1)', backgroundColor: 'rgba(48, 209, 88, 0.1)', borderWidth: 2, tension: 0.3, pointRadius: 4, pointBackgroundColor: 'rgba(48, 209, 88, 1)', fill: true }
                    ]
                },
                options: { /* Options as before */ responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: '新增创新药数量 (款)' } }, x: { title: { display: true, text: '年份' } } }, plugins: { legend: { position: 'top' }, tooltip: { mode: 'index', intersect: false } } }
            };
            safeCreateChart('rdCountChart', rdConfig);

            // --- Market Share Chart ---
            const marketLabels = ['2015', '2016', '2017', '2018', '2019', '2020', '2021', '2022', '2023', '2024E'];
            const totalMarket = [1374, 1534, 1683, 1880, 2119, 2225, 2261, 2321, 2403, 2576];
            const domesticMarket = [257, 305, 350, 430, 556, 713, 817, 940, 1057, 1232];
            const foreignMarket = totalMarket.map((total, i) => total - domesticMarket[i]);
            const marketConfig = {
                type: 'bar',
                data: { /* Data as before */
                    labels: marketLabels,
                    datasets: [
                         { label: '国内企业创新药 Domestic Cos.', data: domesticMarket, backgroundColor: 'rgba(0, 113, 227, 0.7)', borderColor: 'rgba(0, 113, 227, 1)', borderWidth: 1 },
                         { label: '国外企业创新药 Foreign Cos.', data: foreignMarket, backgroundColor: 'rgba(142, 142, 147, 0.7)', borderColor: 'rgba(142, 142, 147, 1)', borderWidth: 1 }
                    ]
                },
                options: { /* Options as before */ responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, stacked: true, title: { display: true, text: '创新药市场规模 (亿人民币)' } }, x: { stacked: true, title: { display: true, text: '年份' } } }, plugins: { legend: { position: 'top' }, tooltip: { mode: 'index', intersect: false } } }
            };
            safeCreateChart('marketShareChart', marketConfig);

             // --- Investment Chart ---
            const investmentLabels = ['2015', '2016', '2017', '2018', '2019', '2020', '2021', '2022', '2023', '2024'];
            const investmentData = [591.21, 772.22, 413.40, 826.84, 1542.99, 2663.67, 2272.56, 1257.97, 1040.82, 891.18];
            const investmentConfig = {
                 type: 'line',
                 data: { /* Data as before */ labels: investmentLabels, datasets: [{ label: '融资金额 (亿人民币)', data: investmentData, borderColor: 'rgba(50, 170, 255, 1)', backgroundColor: 'rgba(50, 170, 255, 0.1)', borderWidth: 2, tension: 0.3, pointRadius: 4, pointBackgroundColor: 'rgba(50, 170, 255, 1)', fill: true }] },
                 options: { /* Options as before */ responsive: true, maintainAspectRatio: false, scales: { y: { beginAtZero: true, title: { display: true, text: '融资金额 (亿人民币)' } }, x: { title: { display: true, text: '年份' } } }, plugins: { legend: { display: false }, tooltip: { mode: 'index', intersect: false } } }
            };
             safeCreateChart('investmentChart', investmentConfig);

              // --- License-Out Chart ---
            const licenseLabels = ['2015', '2016', '2017', '2018', '2019', '2020', '2021', '2022', '2023', '2024'];
            const licenseAmount = [5, 25, 30, 17, 22, 84, 134, 277, 411, 519];
            const licenseCount = [1, 6, 11, 10, 17, 62, 50, 61, 89, 94];
            const licenseOutConfig = {
                type: 'bar',
                data: { /* Data as before */
                    labels: licenseLabels,
                    datasets: [
                        { label: '交易数量 (件)', data: licenseCount, backgroundColor: 'rgba(0, 113, 227, 0.7)', borderColor: 'rgba(0, 113, 227, 1)', yAxisID: 'y1', order: 2 },
                        { label: '总金额 (亿美元)', data: licenseAmount, type: 'line', borderColor: 'rgba(255, 69, 58, 1)', backgroundColor: 'rgba(255, 69, 58, 0.1)', borderWidth: 2, tension: 0.3, yAxisID: 'y', pointRadius: 4, pointBackgroundColor: 'rgba(255, 69, 58, 1)', fill: false, order: 1 }
                    ]
                },
                 options: { /* Options as before */ responsive: true, maintainAspectRatio: false, scales: { y: { type: 'linear', display: true, position: 'left', beginAtZero: true, title: { display: true, text: '总金额 (亿美元)' } }, y1: { type: 'linear', display: true, position: 'right', beginAtZero: true, title: { display: true, text: '交易数量 (件)' }, grid: { drawOnChartArea: false } }, x: { title: { display: true, text: '年份' } } }, plugins: { legend: { position: 'top' }, tooltip: { mode: 'index', intersect: false } } }
            };
             safeCreateChart('licenseOutChart', licenseOutConfig);

        }); // End DOMContentLoaded
    </script>

</body>
</html>